This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Fluid Balance During Closure of Atrial Septal Defect

This study has been completed.
Sponsor:
Collaborator:
University of Bergen
Information provided by (Responsible Party):
Marianne Indrebo, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT01757743
First received: December 21, 2012
Last updated: April 8, 2017
Last verified: April 2017
December 21, 2012
April 8, 2017
February 2013
January 2017   (Final data collection date for primary outcome measure)
Interstitial colloid osmotic pressure [ Time Frame: During surgery or interventional closure ]
Same as current
Complete list of historical versions of study NCT01757743 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Fluid Balance During Closure of Atrial Septal Defect
Protein Distribution and Colloid Osmotic Pressure in Children With Volume and Pressure Loading Due to Congenital Heart Defects
This project will evaluate fluid balance and oedema formation in children with the same congenital heart disease (Atrial Septal Defect) who will either go through heart surgery with the use of Cardio Pulmonary Bypass and hypothermia or through interventional catheterization. The investigators will measure interstitial colloid osmotic pressure, distribution of proteins and cytokines. The study hypothesis is that "Oedema developed during heart surgery is caused by reduced colloid osmotic pressure gradient through the capillary membrane".
Not Provided
Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:
Interstitial fluid Serum
Probability Sample
Children with Atrial Septal Defect scheduled for interventional closure with device or surgical repair
  • Heart Defects,Congenital
  • Heart Septal Defects, Atrial
Not Provided
  • Interventional closure
    Interventional catheterization closure
  • Open Heart Surgery
    Surgery for Atrial septal defect
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
41
January 2017
January 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • The diagnosis of Atrial Septal Defect scheduled for closure
  • Informed consent

Exclusion Criteria:

  • Renal failure,
  • liver failure,
  • coexisting cardiac malformations
Sexes Eligible for Study: All
6 Months to 10 Years   (Child)
No
Contact information is only displayed when the study is recruiting subjects
Norway
 
 
NCT01757743
063.09
No
Not Provided
Undecided
Not Provided
Marianne Indrebo, Oslo University Hospital
Oslo University Hospital
University of Bergen
Principal Investigator: Marianne M Indrebo, MD Oslo University Hospital
Oslo University Hospital
April 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP